banner002.jpg
COVID-19 Update | December 18, 2020
Important Highlights
FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting
(FDA, Dec. 17) 
An initial shipment of 2.9 million doses of the Pfizer/BioNTech vaccine occurred this past week, with the first doses administered on Dec. 14. FDA released a statement on Thursday, Dec. 17 that it is working rapidly “toward finalization and issuance of an emergency use authorization” for the Moderna mRNA COVID-19 vaccine, upon receiving the recommendation by the FDA Vaccines and Related Biological Products Advisory Committee (20-0, with one abstention). ACIP will meet on Saturday and Sunday (see "Events" for ACIP meetings).
 
*UPDATED* Strategies for Optimizing the Supply of Facemasks (CDC) 
This guidance has been updated to include the following:  
  • Added considerations for returning to conventional capacity practices  
  • Conventional Capacity Strategies  
    • Clarified healthcare personnel (HCP) use of facemasks for source control and as PPE to protect their nose and mouth from exposure to splashes, sprays, and respiratory  
  • Contingency Capacity Strategies  
    • Added clarifications on extended use of facemasks as PPE  
    • Added clarifications on restriction on facemask use by HCP as PPE rather than by patients for source control  
  • Crisis Capacity Strategies  
    • Revised section on limited re-use paired with extended use  
    • Deleted the strategies of designating convalescent HCP for the provision of care of patients with SARS-CoV-2 infection, use of expedient patient isolation rooms, and mechanical headboards
  • Incorporated reference to Options to Reduce Quarantine for Contacts of Persons with SARS-CoV-2 Infection Using Symptom Monitoring and Diagnostic Testing  
  • Added recommendation, mirroring testing guidance for community exposures, to test asymptomatic healthcare personnel (HCP) with higher risk exposures to SARS-CoV-2 while at work. 
  • Added considerations for performing expanded screening of asymptomatic HCP without known or suspected exposure to SARS-CoV-2
  • Added links to Frequently Asked Questions addressing Environmental Cleaning and Disinfection and assessing risks to patients and others exposed to healthcare personnel who worked while infected with SARS-CoV-2 
  • Described recommended IPC practices when caring for patients who have met criteria for a 14-day quarantine based on prolonged close contact with someone with SARS-CoV-2 infection. 
  • Added reminders that: 
    • Double gloving is not recommended when providing care to patients with suspected or confirmed SARS-CoV-2 infection 
    • In general, HCP caring for patients with suspected or confirmed SARS-CoV-2 infection should not wear more than one isolation gown at a time.
SHEA Coronavirus News
*UPDATED* SHEA COVID-19 Vaccine Prioritization Statement (Dec. 11) 
SHEA aims to support the effort to promote the vaccine with posts of healthcare leaders who receive it. Help us do this by tagging @SHEA_Epi on Twitter when you receive yours!
Technical Guidance, Standards and Resources
MMWRs
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020 (CDC)  
 
The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020 (CDC)  
 
Trends in County-Level COVID-19 Incidence in Counties With and Without a Mask Mandate — Kansas, June 1–August 23, 2020 (CDC) 
 
Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020 (CDC)  
 
Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino — Denver, Colorado March–October 2020 (CDC) 
 
Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years — Mississippi, September–November 2020 (CDC)  

 
Vaccines
 
Special Settings and Populations
 
Clinical Care
 
Testing and Cases
 
Communication Resources
Information for Patients, Visitors, and the General Public
Event Announcements
Advisory Committee on Immunization Practices (ACIP) Meeting  
Saturday, December 19, 11:00-4:30pm and Sunday, December 20, 11:00-4:30pm  
AGENDA  
ACIP plans to meet to discuss draft recommendations for Moderna’s COVID-19 vaccine.
 
CDC/IDSA COVID-19 Clinician Call: COVID-19 Vaccine Update and Q&A 
Saturday, December 19, 3:00-4:00 pm 
REGISTER 
SPEAKERS: Dana S. Wollins, DrPH, MGC, Jay C. Butler, MD, FAAP, MACP, FIDSA, Hana Mohammed El Sahly, MD, Paul Spearman, MD 
Trade Press, Journal Articles and White Papers
SHEA Education and Events
Converse & Convene: Navigating the Multitude of Guidelines for Key Activities 
Converse and Convene is back! Grab your favorite morning beverage, turn on your camera and come have an open, candid hour-long conversation about how COVID-19 is impacting you, your work, and anything and everything in between. Join us on Friday, January 8 2021 from 11 am-12 pm ET for this virtual networking webinar around “Vaccine Distribution Planning and Implementation” moderated by Marci Drees and David Weber, who will lead and facilitate discussion and collaboration. This webinar will host virtual breakout groups allowing all to be fully engaged with others experiencing similar issues and challenges. Individuals will gain greater insights not only with their breakout groups but with a larger group discussion directly following and led by the moderators. This forum will not be recorded and is meant to be an open conversation. This event is available to SHEA members only, so be sure to register today!
 
SHEA Podcast Series: We’re All in this Together: COVID-19 Allies in Infection Prevention  
This series focuses on the collaborative efforts and opportunities for different disciplines to address and confront the COVID-19 pandemic. Each week's episode will include discussion around what different organizations are doing to address COVID-19, what have been the biggest challenges, what changes have been made, and what opportunities there are to work together to handle the pandemic. Access the full podcast series on LearningCE.
 
SHEA Rapid Response Podcast: COVID-19 Update: What We Know Now 
This series highlights changes in the COVID-19 outbreak and updates in medical literature. Each week's episode will include a summary of important news, a brief summary of medical literature and guidelines on infection prevention that have been published related to COVID-19, and discussion around the latest and most important questions surrounding the outbreak. Access the full podcast series on LearningCE. Tune in to the newest episodes on SoundCloud:  
SHEA Rapid Response Webinars  
Access on LearningCE  
  • Implementation of Electronic Case Reporting (eCR) for COVID-19 
  • Healthcare Facility Outbreak Preparedness  
  • SHEA COVID-19 Town Halls 1-33 
  • SHEA COVID-19 Town Hall, Round 34: Sunday, December 20 | 3:00 pm ET
    REGISTER HERE
Tools and resources include a quick implementation guide that includes a 7-worksheet Excel file with self-populating worksheets to apply implementation concepts and approaches by SHEA members to individual circumstances, and more. 
facebook-2.png twitterlogowhite.png
Click here to unsubscribe.
Powered By Higher Logic

4040 Wilson Blvd, Suite 300, Arlington, VA 22203